HR-770

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHR-770
Drug Alias NameHR-770
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors agonistsHistone deacetylase inhibitors
TargetsRetinoic acid receptorsHistone deacetylase
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHaRo Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHaRo Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsNeuroblastoma

Other Information

ATC CodeN/A
Related LinksN/A